Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
Status:
Unknown status
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess Efficacy and Safety of Extended Adjuvant Treatment
With Letrozole in Postmenopausal Women With Hormone Receptor Positive Breast Cancer Who
Complete 5 Years of Toremifene